AbbVie
ABBV
#29
Rank
C$626.97 B
Marketcap
C$354.80
Share price
-1.44%
Change (1 day)
22.25%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): C$8.20 Billion

According to AbbVie's latest financial reports the company's current earnings are C$62.81 Billion. In 2025 the company made an earning of C$9.12 Billion, an increase over its 2024 earnings that were of C$5.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$8.20 B-10.08%
2025 C$9.12 B77.53%
2024 C$5.14 B-40.54%
2023 C$8.64 B-53.62%
2022 C$18.64 B3.76%
2021 C$17.96 B282.25%
2020 C$4.70 B-59.67%
2019 C$11.65 B62.13%
2018 C$7.18 B-32.74%
2017 C$10.68 B-1.99%
2016 C$10.90 B18.65%
2015 C$9.19 B180.5%
2014 C$3.27 B-55.57%
2013 C$7.37 B-6.86%
2012 C$7.92 B56.05%
2011 C$5.07 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.65 B 77.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.06 B 420.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.57 B 52.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.24 B-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$14.84 B 79.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.27 B 60.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.28 B 145.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$13.85 B 67.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.10 B-86.63%๐Ÿ‡บ๐Ÿ‡ธ USA